Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02481674 |
|---|---|
| Brief Title: | A Study in Subjects With Late Prodromal and Early Manifest Huntington's Disease (HD) to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Pepinemab (VX15/2503) (SIGNAL) |
| First Submitted : | June 19, 2015 |
| First Submitted that Met QC Criteria : | June 23, 2015 |
| First Posted : | June 25, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | September 16, 2020 |
| Last Update Posted : | September 17, 2020 |